Schizophrenia trials in Australia
4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Where
- Brisbane, Melbourne, Westmead
- Age
- 5 years to 17 years
- People
- 400 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07424404 · EU 2025-524062-16-00 - Phase 3Taking peopleA Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Where
- Macquarie Park, Nedlands
- Age
- 55 years to 90 years
- People
- 325 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06947941 - Phase 4Taking peopleBazedoxifene -Treatment for Women With Schizophrenia
- Where
- Melbourne
- Age
- 18 years to 65 years
- People
- 160
- Run by
- The Alfred
See details and how to joinNCT04113993 - No phaseTaking peopleAvatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices
- Where
- Hawthorn
- Age
- 18 years and over
- People
- 212
- Run by
- Swinburne University of Technology
See details and how to joinNCT05982158